Cargando…
Erythrocytes as Carriers of Therapeutic Enzymes
Therapeutic enzymes are administered for the treatment of a wide variety of diseases. They exert their effects through binding with a high affinity and specificity to disease-causing substrates to catalyze their conversion to a non-noxious product, to induce an advantageous physiological change. How...
Autor principal: | Bax, Bridget E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284836/ https://www.ncbi.nlm.nih.gov/pubmed/32397259 http://dx.doi.org/10.3390/pharmaceutics12050435 |
Ejemplares similares
-
Drug-loaded erythrocytes: on the road toward marketing approval
por: Bourgeaux, Vanessa, et al.
Publicado: (2016) -
Erythrocytes as Carriers: From Drug Delivery to Biosensors
por: Koleva, Larisa, et al.
Publicado: (2020) -
Erythrocytes as Carriers for Drugs and Contrast Agents
por: Magnani, Mauro
Publicado: (2014) -
Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017) -
a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy
por: Moraitou, Marina, et al.
Publicado: (2023)